Abstract:Objective To investigate the etiology of early-onset Alzheimer disease which caused by presenilin 1 (PSEN1) mutation in one case of early-onset Alzheimer disease patient with initial symptom of epilepsy childhood and his large family. Methods From November 28, 2014 to November 14, 2015, one case of patient with initial symptom of epilepsy from age of 12 years old who was diagnosed as early-onset Alzheimer disease (the proband) in Department of Neurology of Peking University First Hospital and his large family genealogy (Ⅰ-Ⅳ generations)were recruited as research objects. Diagnostic criteria of Alzheimer disease were as follows. ①Age of onset less than 65 years old. ②The clinical examination evidence supported the diagnosis for dementia; ③Cognitive impairment showed in more than two fields. ④The progressive decline of memory and with other cognitive disorders. ⑤Without disturbance of consciousness. ⑥Without other systemic diseases and the memory and cognitive impairment which can be explained by the brain diseases. The proband, a male, 36 years old had seizures from the age of 12-year-old. He visited the hospital to seek for etiological and to study for his abnormal family history. Clinical data and genomic DNA of the proband and his family members were collected. Targeted next-generation sequencing (TGS) was performed to detect the PSEN1 mutation in the proband. All exons and exon-intron boundaries of PSEN1 were checked by polymerase chain reaction (PCR). Sanger sequencing was used to verify the corresponding mutation. The procedure of this study was consistent with ethical standard established by the committee of investigation in human beings of Peking University First Hospital. And it was approved by this committee. Informed consent was obtained from all participants. Results ①The proband (Ⅲ16) presented with seizures when he was 12 years old. After treated by sodium valproate from the age of 15 years old, the seizure was not observed. He had normal psychomotor development. His cranial MRI showed no abnormality. Relapse occurred when he stopped the drug at the age of 33 years old and sodium valproate remained effective. Primary epilepsy was suspected. However, he have presented with memory loss and disorientation since the age of 35 years old. ②His grandmother (Ⅰ2) had psychiatric disorder in her thirties and died at around 40 years old. His father (Ⅱ6), two aunts(Ⅱ4and Ⅱ5)and two uncles(Ⅱ2and Ⅱ3) presented with similar symptoms, progressive memory loss and mental retroversion at the age of about 35 years old, died in their forties, indicating early-onset Alzheimer disease. ③The sequencing results showed that, in exon 5 of PSEN1of the proband, a reported heterozygous mutation (c.346G>A, p. Glu116Lys) was identified. The same heterozygous mutation was found respectively in his son, a son (Ⅲ11,45 years old) and a grandson (Ⅳ11,7 years old) of a paternal aunt, and a daughter (Ⅲ15,29 years old) of another paternal aunt. The son of the paternal aunt who had the same mutation with the proband was 45 years old without any symptoms. Conclusions Clinical and molecular genetic features of the proband′s pedigree were clearly definite. The results confirmed the diagnosis of early-onset Alzheimer disease. It will be helpful for the genetic counseling and the prenatal diagnosis of the next generation of the family. Key words: Alzheimer disease; Presenilin-1; Epilepsy; Memory disorders; Mental retroversion; DNA mutational analysis; Familial genetic disease

A Pathogenic Variant p.Phe177Val in PSEN1 Causes Early-Onset Alzheimer’s Disease in a Chinese Family

A heterozygous de novo PSEN1 mutation in a patient with early-onset parkinsonism

Mutation Screening in Chinese Patients with Familial Alzheimer's Disease by Whole-Exome Sequencing.

Mutation profile of APP, PSEN1, and PSEN2 in Chinese familial Alzheimer's disease

Identification of a Rare <i>PSEN1</i> Mutation (Thr119Ile) in Late-Onset Alzheimer's Disease With Early Presentation of Behavioral Disturbance

An APP Mutation Family Exhibiting White Matter Hyperintensities and Cortical Calcification in East China

The identification of PSEN1 p.Tyr159Ser mutation in a non-canonic early-onset Alzheimer's disease family

The presenilin 1 mutation P436S causes familial Alzheimer's disease with elevated Aβ43 and atypical clinical manifestations

Clinical And Neuroimaging Characterization Of Chinese Dementia Patients With Psen1 And Psen2 Mutations

Clinical and genetic characteristics in a central-southern Chinese cohort of early-onset Alzheimer's disease

Probable Novel APP Met671Leu Mutation in a Chinese Han Family with Early-Onset Alzheimer's Disease

Familial Alzheimer's Disease Neurons Bearing Mutations in PSEN1 Display Increased Calcium Responses to AMPA as an Early Calcium Dysregulation Phenotype

Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio in Vitro and in Vivo

Genetic Analysis of PICK1 Gene in Alzheimer's Disease: A Study for Finding a New Gene Target

A novel missense variant in ACAA1 contributes to early-onset Alzheimer’s disease, impairs lysosomal function, and facilitates amyloid-β pathology and cognitive decline

Case report: Double mutations in a patient with early-onset Alzheimer's disease in China, PSEN2 and IDE variants

Genetic Influences on White Matter and Metabolism Abnormal Change in Alzheimer's Disease: Meta-analysis for Neuroimaging Research on Presenilin 1 Mutation

A New Presenilin 1 (Psen1) Mutation (p.Cys263Trp) as a Cause of Both Early and Late-Onset Alzheimer's Disease in a Large Italian Family

Very Early-Onset Alzheimer’s Disease in the Third Decade of Life with De Novo PSEN1 Mutations

Cholinergic-like neurons and cerebral spheroids bearing the PSEN1 p.Ile416Thr variant mirror Alzheimer's disease neuropathology

A Patient with Initial Symptom of Epilepsy from Age of 12 Years Old Due to Early-Onset Alzheimer Disease Caused by Presenilin 1 Mutation